HighTower Advisors’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
HighTower Advisors's RPRX Position: Q2 2026 in Review
HighTower Advisors reduced its Royalty Pharma (RPRX) stake by 2.5% in Q2 2026, selling an estimated $379K and leaving 285,630 shares worth $16M. The position accounts for 0.02% of the portfolio, ranked #734.
HighTower Advisors first reported a position in RPRX in Q2 2021 and has held it in 21 quarters since. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- HighTower Advisors held 285,630 shares of Royalty Pharma worth $16M as of Q2 2026.
- HighTower Advisors sold 7,291 Royalty Pharma shares in Q2 2026, an estimated $379K.
- Royalty Pharma made up 0.02% of HighTower Advisors's portfolio in Q2 2026, its #734 holding.
- HighTower Advisors first reported a position in Royalty Pharma in Q2 2021 and has held it in 21 quarters since.
- 645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on HighTower Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.